Teladoc Health (TDOC) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 21, 2026, at 2:00 PM EDT, with virtual attendance available.

• Shareholders are encouraged to review proxy materials and vote by May 20, 2026.

Voting matters and shareholder proposals

• Election of nine directors, each for a one-year term, with all nominees recommended by the board.

• Advisory vote to approve named executive officer compensation (say-on-pay).

• Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.

• Provision to transact any other business that may properly come before the meeting.

Board of directors and corporate governance

• Board recommends all nine director nominees for election.

• Director nominees include Charles Divita III, Sandra L. Fenwick, Catherine A. Jacobson, Kenneth H. Paulus, Susan R. Salka, David L. Shedlarz, Mark Douglas Smith, M.D., MBA, Michael S. Smith, and David B. Snow, Jr.